Introduction
Tropomyosins form a family of actin-binding proteins that influence numerous intracellular functions including actin cytoskeleton dynamics, cell migration, and tumour suppression (Cooper, 2002; Hitchcock-DeGregori et al, 2007; O'Neill et al, 2008) .
Tropomyosin (Tm) has a well-defined function in Drosophila. During oogenesis, the assembly of the posterior pole plasm requires the polarized microtubule-mediated transport of oskar (osk) mRNA to the posterior pole (Clark et al, 1994; Shulman et al, 2000; Tomancak et al, 2000; Doerflinger et al, 2006; Zimyanin et al, 2008) . Osk mediates the nucleation of the pole plasm, which is required for germ cell and abdomen development (Ephrussi et al, 1991; Kim-Ha et al, 1991) . Failure to localize and enrich the pole plasm results in offspring lacking germ cells, referred to as grandchildlessness. Besides mutations in the factors that are required to assemble the pole plasm (e.g., Osk), TmII loss of function also causes grandchildlessness (Erdelyi et al, 1995) . In the developing oocytes of TmII mutant females, the germline determinants do not get localized to the posterior pole plasm because osk mRNA is not properly transported to and localized to the posterior pole, subsequently giving rise to very few germ cells (Erdelyi et al, 1995) . More recent data suggest that TmII is required for osk mRNA trafficking and affects the speed and reversal of the directional bias of particle movement (Singer, 2008; Zimyanin et al, 2008) . Of note, similar to TmII deficiency, mutations in the Drosophila moesin gene that encodes for another actin-binding protein also result in loss of osk mRNA and protein from the posterior subcortical region and failure of oocyte development (Jankovics et al, 2002) . The importance of the actin cytoskeleton for proper targeting and function of Oskar during oocyte development is underscored by the observation that long filamentous actin projections at the oocyte posterior pole are induced by and intermingled with Oskar protein. These data suggest that Oskar maintains its localization to the posterior pole through dual functions in regulating endocytosis and F-actin dynamics (Vanzo et al, 2007) .
The downregulation of high molecular weight Tm isoforms is a common feature observed in many transformed cell lines (Hendricks and Weintraub, 1981; Cooper et al, 1985) and in human tumours (Bhattacharya et al, 1990; Wang et al, 1996; Hughes et al, 2003; Pawlak et al, 2004) . The loss of Tm contributes to the neoplastic phenotype of altered cell shape, loss of stress fibres, and anchorage-independent growth (Boyd et al, 1995) . The transformed phenotype in v-ki-ras transformed NIH3T3 cells and human MDA-MB 231 breast cancer cells can be rescued by reintroduction of Tm1, an isoform of TPMb (Prasad et al, 1993; Bharadwaj et al, 2005) , implying that the loss of Tm is a crucial event in oncogenic transformation. Tm2, an isoform of TPMa, is necessary for transforming growth factor-b-induced stress fibre formation in NMuMG mouse mammary epithelial cells and SiHa human cervical carcinoma cells (Bakin et al, 2004) . Thus, in nonmuscle cells Tm acts as a tumour suppressor and is necessary to maintain actin filament integrity, but the underlying molecular mechanisms remain elusive Hitchcock-DeGregori et al, 2007; O'Neill et al, 2008) .
Rho GTPases can switch between an inactive GDP-bound and an active GTP-bound form (Jaffe and Hall, 2005) . The E3 ubiquitin ligase Smurf1 can bind to nucleotide-free RhoA and promote RhoA ubiquitination, leading to its proteasomal degradation (Wang et al, 2003; Ozdamar et al, 2005) . Synaptopodin is a proline-rich scaffolding protein that is strongly expressed in highly dynamic cell compartments such as dendritic spines in the brain and podocyte foot processes (FPs) in the kidney (Mundel et al, 1997a; Faul et al, 2007) . Similarly to Tm, synaptopodin binds to actin and a-actinin and regulates the actin-bundling activity of a-actinin (Asanuma et al, 2005) . The clinical importance of synaptopodin is underscored by the observation that it is a direct target of the anti-proteinuric effect of the calcineurin inhibitor cyclosporine A (Faul et al, 2008) . Synaptopodin is not a target of proteasomal degradation but instead is degraded by cathepsin L-mediated cleavage (Faul et al, 2008) . Synaptopodin induces stress fibres in podocytes by blocking the Smurf1-mediated ubiquitination of RhoA, thereby preventing the targeting of RhoA for proteasomal degradation (Asanuma et al, 2006; Faul et al, 2007) . As it stands, the general relevance of this mechanism for the regulation of RhoA signalling beyond highly specialized podocytes is unclear.
Tm has long been known to regulate actin dynamics, but the precise mechanisms remained elusive Hitchcock-DeGregori et al, 2007; O'Neill et al, 2008) . Here, we describe the important observation that synaptopodin is sufficient to rescue TmII deficiency in Drosophila by regulating osk mRNA localization and function, which suggests that these two structurally distinct proteins share functional properties. We confirmed this by showing that the mammalian orthologue TPMa regulates stress fibre formation through inhibition of Smurf1-mediated ubiquitination of RhoA in fibroblasts and human cancer cells. Our findings unveil the stabilization of RhoA protein abundance as a mechanism by which TPMa but not TPMb can modulate stress fibre dynamics and cell motility.
Results

Synaptopodin rescues Drosophila TmII loss of function
During Drosophila development, TmII is required for germ cell formation because mutations in TmII (TmII eg9 ) virtually abolish osk mRNA localization to the posterior pole of the oocyte (Erdelyi et al, 1995) . Both Tm and synaptopodin induce actin filaments. To test whether these two structurally distinct actin-binding proteins are interchangeable in vivo, we attempted to rescue the grandchildless phenotype of Drosophila TmII mutants (Erdelyi et al, 1995) by introducing synaptopodin via the Gal4/UAS system (Brand and Perrimon, 1993) . Synaptopodin was expressed in the developing oocyte via the maternal nanos-Gal4 driver (nosGal4, UAS-synpo) and crossed into the TmII eg9 mutant background (Supplementary Figure S1) . The nosGal4, UAS-synpo, TmII eg9 genotype was analysed for osk mRNA localization by in-situ hybridization and quantification of F2 progeny (grandchildren; see Supplementary Figure S1 for details). In both assays, the expression of synaptopodin induced a rescue to wild-type conditions. Osk mRNA localized tightly to the posterior egg pole in rescue flies in a pattern indistinguishable from wildtype flies ( Figure 1A ). The rescue of osk mRNA targeting was functionally relevant, as it led to the production of normal numbers of germ cells deduced by the number of F2 progeny/ grandchildren ( Figure 1B ). Of note, the eggs laid by nossynpo, TmII eg9 developed and hatched normally. We thus conclude that vertebrate synaptopodin can fully substitute for the function of TmII in this in-vivo assay in Drosophila.
Overexpression of synaptopodin induces stress fibres and reduces motility in cancer cells
To test whether synaptopodin and Tm share overlapping functions at the cellular level, we analysed MDA-MB 231 cells that lack stress fibres (Bharadwaj et al, 2005) and express a Tm isoform not found in NIH3T3 fibroblasts (Supplementary Figure S2A) . The transformed phenotype of MDA-MD 231 cells including the loss of stress fibres can be rescued by introduction of Tm1 (Bharadwaj et al, 2005) . To determine whether the ectopic expression of synaptopodin would have a similar effect, we infected MDA-MB 231 cells, which do not express endogenous synaptopodin, with synaptopodin or empty vector ( Figure 2A ). We then visualized the actin cytoskeleton by phalloidin staining ( Figure 2B ). Similar to non-infected MDA-MB 231 cells, only a few cells infected with the empty control vector contained stress fibres. In contrast, synaptopodin overexpression induced stress fibres ( Figure 2B ). Quantitative analysis showed a significant increase in the percentage of stress fibre containing cells after infection with synaptopodin ( Figure 2C ). Functionally, the restoration of stress fibres was associated with the reduction of cell migration as determined by a wound-healing assay ( Figure 2D and E).
Synaptopodin restores stress fibres in TPMa-depleted fibroblasts Similar to synaptopodin in podocytes (Mundel et al, 1997a) , Tm is found along actin filaments in fibroblasts Hitchcock-DeGregori et al, 2007; O'Neill et al, 2008; Figure 3A) . Given that synaptopodin can functionally replace TmII deficiency in Drosophila and human cancer cells, we hypothesized that it may also rescue TPMa depletion in fibroblasts. To directly test this hypothesis, we used a gene silencing approach to reduce the expression of TPMa isoforms in NIH3T3 cells, which do not express endogenous synaptopodin ( Figure 3B ). Gene silencing with a Tm shRNA that recognizes a sequence in TPMa transcript variants 2, 3, 4, 6, and 7, but not with a control shRNA caused the loss of stress fibres ( Figure 3A) , reduction of focal contacts (Supplementary Figure S2B) , and downregulation of Tm protein abundance ( Figure 3B ). Of note, the lentiviral overexpression of synaptopodin ( Figure 3B ) was sufficient to restore stress fibres in TPMa-depleted cells ( Figure 3C , lower panels). Quantitative analysis revealed that synaptopodin significantly increased the percentage of stress fibre containing TPMa knockdown fibroblasts ( Figure 3D ). In order to determine if isoform specificity is important in the loss of stress fibres, we silenced TPMb expression using three independent TPMb-specific shRNAs (Supplementary Figure S3 ). Because the Tm311 antibody detects many Tm isoforms (Tm6, 1, 2, 3, a, b, g muscle Tm) (Nicholson-Flynn et al, 1996) , we performed a semi-quantitative RT-PCR to monitor RNA knockdown. The TPMb shRNAs specifically depleted TPMb isoforms including Tm1 but not TPMa isoforms (Supplementary Figure S3A) . By western blot analysis, we found a reduction of TPMb (upper band) but not TPMa (lower band) protein abundance (Supplementary Figure  S3B) . In contrast to the depletion of TPMa ( Figure 3A) , the depletion of TPMb did not cause the loss of stress fibres (Supplementary Figure S3C and D) . Collectively, these results support the conclusion that TPMa and synaptopodin but not TPMb have overlapping cellular functions in spite of their structural differences.
Lactacystin restores stress fibres in TPMa-depleted fibroblasts NIH3T3 cells, MDA-MB 231 cancer cells, and podocytes, serving as a positive control (Asanuma et al, 2006) , express the E3 ubiquitin protein ligase Smurf1 (Supplementary Figure  S2C) , which can induce the proteasomal degradation of RhoA (Wang et al, 2003; Asanuma et al, 2006; Sahai et al, 2007) . In fibroblasts, gene silencing of TPMa reduced RhoA steadystate protein levels ( Figure 4A ). This raised the possibility that TPMa depletion, by analogy to synaptopodin depletion (Asanuma et al, 2006) , may result in Smurf1-induced degradation of RhoA. In keeping with this hypothesis, the proteasome inhibitor lactacystin increased RhoA protein abundance ( Figure 4A ) and the percentage of stress fibre containing TPMa knockdown fibroblasts ( Figure 4B and C). The upregulation of stress fibres by lactacystin was independent of Tm, because Tm protein abundance remained unchanged ( Figure 4A ). To confirm these results with an independent approach, we infected TPMa knockdown fibroblasts with wild-type RhoA or RhoA(K6,7R) that is resistant to Smurf1-mediated ubiquitination and proteasomal degradation (Wang et al, 2003; Ozdamar et al, 2005) . Infection with FLAGRhoA(K6,7R) but not with wild-type FLAG-RhoA or empty vector restored stress fibres in TPMa knockdown fibroblasts ( Figure 4D ). Overexpression of FLAG-RhoA was confirmed by western blot analysis ( Figure 4E ). Quantitative analysis showed a significant increase in the percentage of stress fibre containing Tm knockdown cells infected with Smurf1-resistant FLAG-RhoA(K6,7R) but not with wild-type FLAG-RhoA ( Figure 4F ). Collectively, these data establish a competitive relationship between Smurf1-mediated ubiquitination of RhoA and Tm activity. mutant, nos-synpo transgenic, and nos-synpo/TmII eg9 transgenic flies were analysed. The average egg count was 110±16% (n ¼ 1253) for wildtype (WT) flies and 90±16% (n ¼ 1085) for synaptopodin transgenic flies versus 10±6% (n ¼ 146) for the TmII eg9 genotype. The nosGal4, UAS-synpo, TmII eg9 flies displayed WT levels: 94 ± 15% (n ¼ 1008). *Po0.0001, Student's t-test.
Rho kinase inhibition abrogates synaptopodin-or lactacystin-induced stress fibres in TPMa-depleted fibroblasts
Synaptopodin induces stress fibres in podocytes by increasing RhoA abundance and activation (Asanuma et al, 2006) . Now, we find that ectopic synaptopodin expression also induces stress fibres in TPMa-depleted fibroblasts ( Figure 3 ). To demonstrate that this effect is dependent on an increase of RhoA, we used the Rho kinase inhibitor Y-27632 to block synaptopodin-induced stress fibres in TPMa-depleted fibroblasts ( Figure 5A and B). Similarly, Y-27632 blocked lactacystin-induced stress fibres ( Figure 5A and C). These results confirm that synaptopodin-or lactacystin-induced stress fibre formation depends on RhoA and Rho kinase signalling.
Tm regulates stress fibre formation and cell migration in MDA-MB 231 breast cancer cells through inhibition of RhoA ubiquitination
Given that lactacystin restores stress fibres in TPMa-depleted fibroblast, we asked if lactacystin also affected RhoA protein abundance and stress fibre formation in MDA-MB 231 cells. Similarly to podocytes (Asanuma et al, 2006) and TPMa knockdown fibroblasts ( Figure 4A ), lactacystin increased RhoA steady-state protein levels in MDA-MB 231 cells ( Figure 6A ). As in TPMa knockdown cells ( Figure 4B and C), lactacystin induced stress fibres in MDA-MB 231 cancer cells ( Figure 6B and C). The induction of stress fibres was independent of Tm because it did not change Tm protein abundance ( Figure 6A ). To determine whether the ectopic expression of Smurf1-resistant RhoA(K6,7R) (Wang et al, 2003; Ozdamar et al, 2005) would have a similar effect as the overexpression of synaptopodin or lactacystin treatment, we infected MDA-MB 231 cells with empty vector, FLAGRhoA or Smurf1-resistant FLAG-RhoA(K6,7R) ( Figure 6D ). Similarly to synaptopodin ( Figure tested whether Tm can also bind to RhoA. We found that both GFP-tagged Tm1 (encoded by the TPMa gene) and GFPtagged Tm2 (encoded by the TPMb gene) but not the GFP control (GFP-sui) could bind to dominant-active FLAGRhoA(G14V) and dominant-negative FLAG-RhoA(T19N) in co-transfected HEK293 cells ( Figure 7A ). GFP-Tm1 and GFP-Tm2 did not bind to the FLAG control (FLAG-Cdc42) ( Figure 7A ), confirming the specificity of the interaction.
Synaptopodin can displace Smurf1 from GDP-bound RhoA, thereby suppressing the Smurf1-mediated ubiquitination of GDP-RhoA (Asanuma et al, 2006) . To test whether Tm2 can compete with Smurf1 for RhoA binding, we conducted in vitro reconstitution assays according to our published protocols Asanuma et al, 2006; YanagidaAsanuma et al, 2007) . In the absence of Tm2, purified Smurf1 bound to GST-RhoA(T19N), but not to the GST control. However, with the addition of increasing amounts of purified FLAG-Tm2 protein, the binding of FLAG-Smurf1 to GSTRhoA(T19N) progressively decreased, with a concomitant increase in Tm2 binding to GST-RhoA ( Figure 7B ). To test whether the observed inhibition of Smurf1 binding to RhoA by Tm2 is functionally relevant, we performed co-transfection studies in HEK293 cells using FLAG-RhoA(T19N), Myc-Smurf1 (wild-type or catalytically inactive, CA) and HA-ubiquitin in the presence of GFP-Tm1, GFP-Tm2, or GFP alone ( Figure 7C ). In cells expressing the GFP control, RhoA was strongly ubiquitinated by Smurf1, as expected from previous studies (Wang et al, 2003; Asanuma et al, 2006) . In keeping with previous studies (Asanuma et al, 2006) , the ubiquitination of RhoA was markedly reduced in cells co-transfected with synaptopodin. Similarly, the ubiquitination of RhoA was markedly reduced in cells coexpressing Tm2 but not in cells coexpressing Tm1 or a-actinin-4, another actin-binding protein serving as a negative control (Asanuma et al, 2006 ; Figure 7C ). Reduced ubiquitination of RhoA was also found in cells expressing catalytically inactive Smurf1(CA) ( Figure 7C ). Although we did not conduct a two step IP experiment to explore the effects of Tm on RhoA ubiquitination, collectively our data suggest that at least one isoform of TMPa, Tm2, but not the TPMb isoform Tm1, can block the Smurf1-mediated ubiquitination and proteasomal degradation of RhoA.
The half-life of synaptopodin is markedly shorter than that of Tm In podocytes, Tm is localized to the cell body (Drenckhahn et al, 1990) , whereas synaptopodin is found in FPs (Mundel et al, 1997a; Faul et al, 2007) . FPs are highly dynamics structures, so rapid changes in FP morphology require dynamic control of their actin cytoskeleton, a function thought to be subserved by synaptopodin . Synaptopodin is readily degraded by TRPC5/Ca 2 þ -induced (Tian et al, 2010 ) and calcineurin/cathepsin L-mediated proteolysis (Faul et al, 2008) . On the other hand, Tm in cardiac myocytes is highly stable (Martin, 1981) , and therefore an unlikely candidate for dynamic, rapid actin cytoskeleton remodelling. To compare the half-life of synaptopodin with that of Tm, we overexpressed FLAG-synaptopodin or FLAG-Tm2 in HEK293 cells. The cells were treated with cycloheximide to block de-novo protein synthesis and the levels of both proteins were followed over time. Synaptopodin was rapidly degraded (Supplementary Figure S3D) with a calculated half-life of 14.6 ± 4.5 h. In contrast, Tm2 remained stable over the entire course of the experiment (24 h), in keeping with its previously reported long half-life of about 5.5 days in myocytes (Martin, 1981) . To validate the results in the context of endogenous proteins, we examined the turnover of synaptopodin and Tm in podocytes. The estimated half-life of endogenous synaptopodin in podocytes was 17.1±2.4 h ( Figure 7D ), similarly to exogenous synaptopodin in HEK293 cells. As in HEK293 cells, endogenous Tm in podocytes remained stable over the course of the experiment ( Figure 7D ).
Discussion
The results of this study revealed that synaptopodin can rescue Tm deficiency by functional mimicry in vitro in cancer cells and fibroblasts and in vivo in Drosophila. The stabilization of RhoA abundance offers a molecular mechanism by which Tm can regulate stress fibre dynamics. Our results show further that Tm can induce stress fibres by blocking the Smurf1-mediated ubiquitination of RhoA, thus protecting RhoA against proteasomal degradation. Our findings support the notion that, in addition to the regulation by guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine nucleotide-dissociation inhibitors (GDIs) (Jaffe and Hall, 2005) , the proteasomal degradation of RhoA is a conserved mechanism for the control of RhoA signalling, stress fibre dynamics, and cell motility ( Figure 7E ). The level of RhoA protein can be regulated by the ubiquitin-proteasome system through multiple mechanisms. Besides Smurf1, the Cullin3-BACURD complex can also regulate RhoA degradation (Chen et al, 2009 ). This study showed that Smurf1-resistant RhoA(K6,7R) is sufficient to rescue stress fibres in TPMa depleted fibroblast and MDA-MB 231 cancer cells. Thus, Tm probably does not affect Cullin3-BACURD-mediated degradation of RhoA. Future studies are needed to confirm or refute this idea.
A further interesting outcome of this study is the identification of RhoA as Tm-binding protein. In muscle cells, Tm interacts with troponin T, caldesmon, and tropomodulin as part of the contractile apparatus (Perry, 2001) . In non-muscle cells, various Tm isoforms bind to calponin (Takahashi et al, 1986) , pEL98 (Takenaga et al, 1994) , and glutamic dehydrogenase (Akutsu and Miyazaki, 2002) although the physiological significance of these interactions is largely unknown. By linking Tm directly to RhoA signalling, we establish a new paradigm in which structurally unrelated actin-binding proteins such as Tm and synaptopodin not only serve as passive structural components of actin filaments, but also can actively regulate stress fibre dynamics ( Figure 7E ).
Our results demonstrate that Tm and synaptopodin employ similar molecular mechanisms by which they regulate actin dynamics, cell migration, and oocyte differentiation. The functional similarities between both proteins are underscored by the observation that synaptopodin is not only sufficient to rescue RhoA signalling in TPMa-depleted fibroblasts and human cancer cells in vitro, but also osk mRNA localization and fertility in TmII eg9 mutant flies in vivo. Synaptopodin not only blocks the proteasomal degradation of RhoA (Asanuma et al, 2006) , but also elongates a-actinininduced actin filaments (Asanuma et al, 2005) , another function that is shared by Tm (Hitchcock-DeGregori et al, 2007) . Synaptopodin and Tm2 can prevent ubiquitination of RhoA and thereby cause its stabilization, thus allowing the formation of actin stress fibres necessary for proper regulation of cell migration and possibly osk mRNA localization. Mammalian Tm2 is not the same as TmII in Drosophila. Therefore, future studies will be necessary to establish more precisely the molecular link between TmII in Drosophila and Tm2 in mammals and to determine whether synaptopodin rescues TPMa deficiency by virtue of restoring RhoA signalling, through the restoration of Oskar-induced long action projections (Vanzo et al, 2007) or via regulation of osk mRNA trafficking or anchoring (Singer, 2008; Zimyanin et al, 2008) .
The outcome of the half-life studies suggests that synaptopodin is better poised to mediate rapid temporal changes in actin dynamics, while Tm seems better suited for maintaining a more static actin cytoskeleton. This notion is further supported by the observation that synaptopodin is a target of rapid TRPC5/Ca 2 þ and calcineurin-dependent degradation (Faul et al, 2008; Tian et al, 2010) . Therefore, our results suggest another mechanism for spatial and temporal regulation of the actin cytoskeleton in highly dynamics polarized cells such as podocytes or neurons.
To start exploring the question of isoform specificity, we established that in contrast to TPMa depletion, gene silencing of TPMb is not sufficient to cause a loss of stress fibres in fibroblasts. Together with our finding that Tm1, which is encoded by the TPMb gene, is not sufficient to block the ubiquitination of RhoA, these findings merit further investigation in future studies to determine the underlying molecular basis of isoform specificity. For example, Tm1 or a subset of other Tm isoforms may be proven to control stress fibre dynamics via other mechanisms such as regulation of RhoA GEFs or GAPs (Jaffe and Hall, 2005) .
In summary, this work provides novel insights into Tm signalling. Our results suggest that the regulation of stress Figure 7 Tm2 blocks the ubiquitination of RhoA by Smurf1. (A) GFP-Tm1 and GFP-Tm2 interact with dominant-active (G14V) and more strongly with dominant-negative (T19N) RhoA but not with the negative control GFP-sui (GFP control). GFP-Tm1 and GFP-Tm2 do not interact with FLAG-Cdc42 (FLAG control) also serving as negative control. (B) Immobilized GST-RhoA(T19N) but not GST alone directly binds to purified FLAG-Smurf1. In the presence of increasing amounts of FLAG-Tm2, the binding of RhoA to Smurf1 is gradually lost, and concomitantly increased binding of Tm2 to RhoA is detected. In the presence of 1 mg of FLAG-Tm2, only Tm2 binds to RhoA. (C) FLAG-RhoA is ubiquitinated by wild-type (WT) but not by catalytically inactive (CA) Myc-Smurf1 in transfected HEK293 cells expressing GFP as revealed by anti-HA immunoblotting. GFP-Tm2 and GFP-Synaptopodin (Synpo) but not GFP-Tm1 or GFP-a-actinin-4 (Act-4) markedly reduces the ubiquitination of RhoA. No RhoA ubiquitination is detected in the absence of HA-ubiquitin. (D) Synaptopodin and Tm differ in their protein half-life. Treatment of podocytes with cycloheximide results in the rapid degradation of endogenous synaptopodin with a calculated half-life of 17.1 ± 2.4 h. In contrast, Tm protein abundance remains stable over the entire 24-h observation period. (E) An extended model for the regulation of RhoA signalling. In the canonical model of the Rho GTPase cycle, the activity of Rho GTPases is regulated by a switch between an inactive GDP-bound and an active GTP-bound form. The cycle is tightly regulated mainly by guanine exchange factors (GEFs), GTPaseactivating proteins (GAPs), and guanine dissociation inhibitors (GDIs). Tm and synaptopodin promote stress fibre formation through the inhibition of Smurf1-mediated ubiquitination of RhoA. Thus, repression of Smurf1-induced proteasomal degradation of RhoA by structurally unrelated actin-binding proteins is a conserved mechanism for the regulation of RhoA signalling, in addition to the GDP/GTP switch. fibre dynamics by Smurf1-mediated degradation of RhoA is not only essential in highly specialized cell such as podocytes (Asanuma et al, 2006) , but also represents a conserved mechanism for the regulation of stress fibre dynamics and cell motility by the structurally distinct but functionally similar actin-binding proteins Tm2 and synaptopodin.
Materials and methods
Plasmid constructs
Mouse Tm2 cDNA was obtained from ATCC (GenBank ID BC026720). Rat Tm1 cDNA was provided by Peter W Gunning, GST-RhoA(T19N) by Tadaomi Takenawa, Smurf1-resistant RhoA(K6,7R) by Jeffrey L Wrana, wild-type and CA Smurf1 by Takeshi Imamura. cDNAs were subcloned by PCR amplification into pEGFP-C1 (Clontech), pFLAG-6c or pFLAG-5a (Sigma). All constructs were verified by DNA sequencing. FLAG-synaptopodin long and FLAG-a-actinin-4 constructs have been described previously (Asanuma et al, 2005 (Asanuma et al, , 2006 . Synaptopodin was amplified by PCR from GFP-synaptopodin long (Asanuma et al, 2005) and cloned into the LXSN vector (Clontech). Synaptopodin, wild-type FLAGRhoA, and FLAG-RhoA(K6,7R) were also cloned into the pLentix (Clontech) vector. The GIPZ TPMa shRNA and GIPZ non-silencing control shRNAs were acquired from Open Biosystems. The GIPZ TPMa shRNA (Open Biosystems, Catalog Number RMM4431-98754654, Clone ID V2LMM_25293shRNA) is targeted to the following sequence: CACTACATATGTAATTGGT. When blasted, the shRNA matches TPM1 transcript variants 2, 3, 4, 6, and 7. The GIPZ TPMb shRNAs (Open Biosystems) target the following sequences: AAATACGAAGAAGAGATCA (#1), CGGACAAGTATTCCACCAA (#2), and CCGAGCAGAGTTTGCTGAA (#3). The Open Biosystems TPMa shRNA targets a sequence in exon 9D of TPMa that is predicted to knockdown isoforms Tm6, Tm2, Tm3, Tm5a, and Tm5b. This is not predicted to knockdown any TPMb isoforms, including Tm1.
RNA isolation and RT-PCR
NIH3T3 cells were lysed from a 10-cm dish and homogenized by passing through a QIAshredder (Qiagen). RNA was isolated using the RNeasy Mini Kit according to the manufacturer's protocol. cDNA was synthesized from 200 to 350 ng total RNA using oligo(dT) 20 and SuperScript III RT (Invitrogen) according to the manufacturer's protocol. In all, 1 ml cDNA was amplified by PCR (30 cycles at 941C for 30 s, 581C for 30 s, 721C for 30 s) using Choice-Taq DNA Polymerase (Denville Scientific). The primer sets used were GAPDH (5 0 -CCAATGTGTCCGTCGTGGATCT-3 0 ; 5 0 -GTTGAAGTCGCA GGAGACAACC-3 0 ), TPMb (5 0 -TGGCTGAGAGTAAATGTGGGGACC-3 0 ; 5 0 -CAGGCTGGCTGTGCAACGTG-3 0 ), and TPMa (5 0 -AGGAGGCTGA AACTCGGGCTGA-3 0 ; 5 0 -TGGCCGCAGCTAAGGAGGGT-3 0 ). TPMa amplifies TPMa transcript variants 2, 3, 4, 6, and 7.
Cell culture and transient transfection NIH3T3 cell, which express Tm1, Tm2, Tm3, Tm6, Tm5a, Tm5b, Tm5NM1, and Tm5NM2 (Percival et al, 2000; Schevzov et al, 2005) , was cultured in DMEM (Gibco) with 10% newborn calf serum (Invitrogen or Sigma) and 100 units/ml of penicillin-streptomycin (Invitrogen). Podocytes and HEK293 cells were cultured as described previously (Mundel et al, 1997a; Asanuma et al, 2005 Asanuma et al, , 2006 . MDA-MB 231 cells were obtained from ATCC and cultured as recommended. Transient transfection of HEK293 cells was performed as described before (Asanuma et al, 2005) . For proteasome inhibition, NIH3T3 was treated for 16 h with 5-10 mM lactacystin (Santa Cruz) and MDA-MB 231 for 8 h with 2.5 mM lactacystin (Asanuma et al, 2006) . For the Rho kinase inhibitor studies, MDA-MB 231 cells were treated with 10 mM Rho kinase inhibitor (Y-27632, Sigma) or the vehicle control (DMSO) for 1 h prior to fixation and stress fibre quantification. In experiments where NIH3T3 cells were treated with both lactacystin and Y-27632, fibroblasts were first treated with 5 mM lactacystin for 15 h before 5 mM Y-27632 was added to the media for another hour. GFP fusion proteins were analysed by direct fluorescence microscopy in living cells or after fixation and double labelling confocal microscopy (Asanuma et al, 2005 (Asanuma et al, , 2006 . Stress fibres were counted manually in each individual cell in independent images. A stress fibre was defined as a phalloidin-positive structure that was represented by a line spanning across the length of the cell. In all, 200 TPMadepleted NIH3T3 cells and 100 MDA-MB 231 cells from three independent experiments were analysed for the presence of stress fibres. In addition, for each TPMb shRNA 100 cells were counted. A P-value o0.05 with the Student's t-test was considered statistically significant.
Lentivirus production
The GIPZ plasmids (TPMa, TPMb shRNA, or control shRNA) and the pLentix plasmids (FLAG-RhoA, FLAG-RhoA(K6,7R), and synaptopodin), along with the helper plasmids psPAX2 and pMD2.G were transfected into HEK293T cells at 70% confluence using Lipofectamine 2000 (Invitrogen) or Fugene 6 (Roche). LXSN vector (LXSN vector only and LXSN-synaptopodin)-based retroviruses were prepared by transient transfection of the retroviral vectors in Phoenix cells, which stably express the packaging plasmids. Media was replaced 16-18 h after transfection. In all, 36 and 60 h after transfection, virus-containing supernatants were harvested and centrifuged at 3000 r.p.m. for 5 min. Viral particles were then passed through a 0.45-mm filter (Corning) and supernatants were used for infection of target cells in the presence of 4 mg/ml polybrene (Sigma). NIH3T3 cells were infected for 24 h and then selected. Non-infected cells were removed by selection in either 2 mg/ml puromycin (Sigma) for GIPZ vectors or 0.7 mg/ml G418 (Gibco) for LXSN and pLentix constructs, respectively. Non-infected MDA-MB 231 cells were selected with 3 mg/ml G418.
Drosophila histology and in-situ hybridization
Nos-Gal4 is Gal4HVP16-nos.UTR. Females of wild type, TmII eg9 mutant, nos-Gal4, UAS-synaptopodin/ þ and nos-Gal4, UASsynaptopodin/ þ ; TmII eg9 genotypes were selected from the intercross of nos-Gal4/w FM6; TmII eg9 /TM6b and UAS-synaptopodin; Tm2 eg9 /TM6 Ubx. Expression of synaptopodin in the germline during oogenesis was confirmed by immunofluorescence microscopy. In-situ hybridization was performed on all four genotypes according to Tautz and Pfeifle (1989) with modifications for RNA probes and ovaries. A digoxigenin-labelled antisense osk mRNA probe was generated with T7 RNA polymerase (Roche). Hybridization was performed at 551C. Ovaries of 10-15 females per genotype were separated into ovarioles and fixed in 4% paraformaldehyde (PFA) in PBS containing 0.1% Tween-20/DMSO/heptane in a 20:2:60 mixture at room temperature for 20 min with agitation. The heptane phase was removed and replaced by 50 parts 4% PFA in PBS containing 0.1% Tween-20 followed by further incubation for 5 min with agitation. Ovaries were rehydrated in methanol/4% PFA in PBS containing 0.1% Tween-20 in a 1:1 mixture for 5 min and processed as described by others (Tautz and Pfeifle, 1989) . Immunolabelling of Drosophila ovaries was done according to protocols described by the Cooley laboratory (http://info.med.yale. edu/cooley/Protocol%20Ovaries.html).
Immunocytochemistry
Cultured cells were plated on coverslips and fixed with 2% PFA and 4% sucrose in PBS for 10 min followed by permeabilization with 0.3% Triton X-100 in PBS for 5 min at room temperature. After three 5 min washes with PBS, non-specific binding sites were blocked with 2% FCS, 2% BSA, and 0.2% fish gelatin in PBS for at least 30 min. Primary antibodies (prediluted in blocking solution) were applied for 60 min at room temperature. Antigen-antibody complexes were visualized using Alexa Fluor 488 or 647 conjugated secondary antibodies at 1:500 to 1:1000 (Molecular Probes). Stress fibres were visualized by staining with rhodamine-labelled phalloidin (Molecular Probes) at 1:750 for 30 min along with the secondary antibodies. Cells were washed with PBS, rinsed with ddH 2 O, and mounted in 15% Mowiol and 50% glycerol in PBS. Monoclonal anti-Tm (Tm311, Sigma) and anti-vinculin (Sigma) were used at 1:400. Confocal images were captured on a Leica TC5 SP5 or a Zeiss LSM 510 upright confocal microscope. ImageJ and Photoshop softwares were used for image analysis.
Western blotting and immunoprecipitation SDS-PAGE, western blotting, and co-immunoprecipitation of FLAGand GFP-tagged fusion proteins from transfected HEK293 cells were performed as described previously (Asanuma et al, 2005 (Asanuma et al, , 2006 . It was previously found by others that an N-terminally tagged Tm1 is unable to induce stress fibres in transformed cells (Bharadwaj et al, 2004) . Therefore, we cloned the tropomyosin constructs used in the present study into pFLAG-CMV-5 vectors, thereby placing the tags on the C-terminus and avoiding interfere with the critical function of the N-terminal domain (Bharadwaj et al, 2004) . This is in keeping with other studies that have also successfully used C-terminal FLAG-Tm constructs for localization and functional studies (Michele et al, 1999; Hillberg et al, 2006) . Protein extraction from isolated mouse glomeruli has been described before (Mundel et al, 1997b; Asanuma et al, 2005) . Antibodies were used as follow: Synaptopodin NT (Mundel et al, 1997a) at 1:1000, FLAG (Sigma) at 1:10 000, GFP (BD Transduction Laboratories) at 1:1000, GAPDH (Calbiochem) at 1:3000, RhoA (Cell Signaling) at 1:1000, and Tm (Tm311, Sigma) at 1:1000. The Tm311 antibody recognizes a common epitope in the long Tm isoforms (Nicholson-Flynn et al, 1996) . HRP-conjugated secondary antibodies (Promega) were used at 1:10 000.
GST binding assays
To study the competitive binding of Tm2 and Smurf1 to RhoA, GST pull-down studies with purified recombinant proteins were carried out as described previously for synaptopodin (Asanuma et al, 2006) . Recombinant proteins were bound to GST or GSTRhoA(T19N) in Triton buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100) and washed five times in Triton buffer. We immobilized 1 mg purified GST-RhoA(T19N) on GSH beads and incubated it with 0.5 mg of purified FLAG-tagged catalytically inactive Smurf1(CA) (Wang et al, 2003) and increasing amounts (0, 0.25, 0.5, or 1 mg) of FLAG-Tm2.
Wound-healing assays
Cell migration of wild-type MDA-MB 231 cells and MDA-MB 231 cells infected with empty pLentix vector, pLentix-FLAG-RhoA(wt), pLentix-FLAG-RhoA(K6,7R) or pLentix-synaptopodin was assessed using a wound-healing assay. The cells were plated in 24-well plates and allowed to proliferate to form a confluent monolayer. A 200-ml pipette tip was used to scratch a single wound through the middle of the cell monolayer. Cells were fixed with methanol and stained with crystal violet at 0 and 12 h post wounding. Stained cells were imaged by use of a light microscope equipped with an Olympus digital camera. The percent wound closure at the 12-h time point was compared with determine differences in the rate of cell migration. In each experiment, we analysed a total n ¼ 6.
Protein half-life assays
To determine the turnover of exogenous synaptopodin and Tm2, we transfected HEK293 cells with FLAG-synaptopodin or FLAG-Tm2. Forty-eight hours later, the cells were treated with 10 mg/ml cycloheximide (Sigma-Aldrich) for indicated times (0, 1, 2, 4, 8, 12 , and 24 h). Protein extracts were prepared in CHAPS buffer (20 mM Tris pH 7.5, 500 mM NaCl, 0.5% CHAPS) and synaptopodin and tropomyosin levels were quantified using ImageJ software. GAPDH levels were used as an internal loading control and the protein levels at the beginning of the experiment (0 h) as 100%. Using the best-fit curve, half-life of each protein was determined and reported as average±standard deviation of four independent experiments. To analyse the half-life of endogenous synaptopodin and Tm in podocytes, we differentiated podocytes for 10 days as described before (Mundel et al, 1997b) . The podocytes were then treated with 10 mg/ml cycloheximide for indicated time points (0, 4, 8, 12, 16, and 24 h) . Protein extracts were prepared in CHAPS buffer and the half-life of synaptopodin and tropomyosin was determined from three independent experiments as described above. Tropomyosin was detected with Tm311 antibody as described above.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
